1.44
price up icon14.29%   0.18
after-market Dopo l'orario di chiusura: 1.45 0.01 +0.69%
loading

Context Therapeutics Inc Borsa (CNTX) Ultime notizie

pulisher
11:41 AM

Is Context Therapeutics Inc. stock positioned well for digital economyMarket Movers & Fast Entry Momentum Trade Alerts - newser.com

11:41 AM
pulisher
11:36 AM

Is Context Therapeutics Inc. stock a defensive play in 2025Market Activity Summary & Weekly High Return Stock Forecasts - newser.com

11:36 AM
pulisher
05:42 AM

Context Therapeutics Inc. recovery potential after sell offEarnings Recap Report & Accurate Technical Buy Alerts - newser.com

05:42 AM
pulisher
01:18 AM

What drives Context Therapeutics Inc stock priceGrowth vs. Value Investing & Free High Yield Growth Strategies - earlytimes.in

01:18 AM
pulisher
Oct 16, 2025

D. Boral Capital Maintains Context Therapeutics (CNTX) Buy Recommendation - Nasdaq

Oct 16, 2025
pulisher
Oct 16, 2025

Applying chart zones and confluence areas to Context Therapeutics Inc.2025 Price Momentum & AI Enhanced Trading Alerts - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Is Context Therapeutics Inc a good long term investmentMonthly Performance Summary & Access Free Tools and Start Investing - earlytimes.in

Oct 15, 2025
pulisher
Oct 15, 2025

Is Context Therapeutics Inc. stock in correction or buying zone2025 Big Picture & Weekly High Return Opportunities - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Does Context Therapeutics Inc. stock trade at a discount to peersEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Can a trend reversal in Context Therapeutics Inc. lead to recoveryJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Momentum divergence signals in Context Therapeutics Inc. chartGap Down & Stepwise Trade Signal Implementation - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

How to use Fibonacci retracement on Context Therapeutics Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Context Therapeutics to Present New Data on Two Bispecific T Cell Engagers at SITC 2025 - MyChesCo

Oct 12, 2025
pulisher
Oct 11, 2025

Context Therapeutics to Showcase CT-95 Data at AACR 2025 - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

Is Context Therapeutics Inc. stock ready for a breakoutNew Guidance & Low Risk Entry Point Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Context Therapeutics Inc. continue its uptrendLayoff News & AI Based Buy and Sell Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Historical volatility pattern of Context Therapeutics Inc. visualizedQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time social sentiment graph for Context Therapeutics Inc.Portfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Live market analysis of Context Therapeutics Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Context Therapeutics Inc. stock momentum explained2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Context Therapeutics (NASDAQ:CNTX) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

How Context Therapeutics Inc. stock trades before earningsQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is a relief rally coming for Context Therapeutics Inc. holdersIndex Update & AI Driven Stock Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Context Therapeutics Inc. showing signs of accumulationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo Finance

Oct 08, 2025
pulisher
Oct 07, 2025

Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.20 Consensus PT from Analysts - Defense World

Oct 07, 2025
pulisher
Oct 06, 2025

Context Therapeutics Grants Stock Options to New Hire - MSN

Oct 06, 2025
pulisher
Oct 06, 2025

Will Context Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Context Therapeutics Inc. to Present Trial Progress and Preclinical Data at SITC 2025 Annual Meeting - Quiver Quantitative

Oct 06, 2025
pulisher
Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of ... - Caledonian Record

Oct 06, 2025
pulisher
Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Is it too late to sell Context Therapeutics Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Context Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Developing predictive dashboards with Context Therapeutics Inc. dataJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline - MyChesCo

Oct 05, 2025
pulisher
Oct 04, 2025

Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Context Therapeutics announces inducement grant under Nasdaq listing rule - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

GlobeNewswire by Notified - The Manila Times

Oct 03, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):